Filing Details

Accession Number:
0001237899-13-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-20 16:24:13
Reporting Period:
2013-09-18
Filing Date:
2013-09-20
Accepted Time:
2013-09-20 16:24:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226687 William Roberts 777 Old Saw Mill River Road
Tarrytown NY 10591
Vp Reg Dev & Med Safety No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-13 4,000 $0.00 20,644 No 5 G Direct
Common Stock Acquisiton 2013-09-18 15,000 $16.80 35,644 No 4 M Direct
Common Stock Disposition 2013-09-18 15,000 $304.00 20,644 No 4 S Direct
Common Stock Disposition 2013-09-19 4,000 $0.00 16,644 No 4 G Direct
Common Stock Disposition 2013-06-13 4,000 $0.00 13,447 No 5 G Indirect by Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 S Direct
No 4 G Direct
No 5 G Indirect by Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-09-18 15,000 $0.00 15,000 $16.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,048 2018-12-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,000 Indirect by GRAT
Common Stock 1,200 Indirect by trust for daught
Common Stock 4,388 Indirect By 401(k) Plan
Common Stock 1,200 Indirect by trust for daught
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Gift of Common Stock to a charitable foundation.
  3. The stock option award vests in four equal annual installments, commencing one year after the date of grant.